BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
BillionToOne, Inc.NASDAQ: BLLN
Retained Earnings · Q2 FY2026 · quarter ended Jun 2026
Retained earnings remains negative
Q2 FY2026 retained earnings was -$248.72M, compared with -$286.44M a year earlier.
Context
- Retained earnings amounted to 34.1% of total assets at the end of Q2 FY2026, down 57.5 pp from a year earlier.
- Retained earnings grew in size in 1 of the last 2 fiscal years.
What to watch
Whether retained earnings keeps rising in the next quarterly balance sheet after a +13.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Retained Earnings history
USD · from the balance sheet
- Latest · FY2025
- (274.75M) USD
- Year-over-year change
- +2.6%
| Period | Period end | Retained Earnings | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (274.75M) | +2.6% |
| FY2024 | 2024-12-31 | (282.2M) | -17.3% |
| FY2023 | 2023-12-31 | (240.63M) | — |
Retained Earnings vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 retained earnings of -$248.72M is the 2nd highest of the 9 companies compared; the peer median is -$1.31B.
- Its year-over-year change of +13.2% is the 2nd highest of 9, against a peer median of -10.3%.
- Retained earnings amounts to 34.1% of total assets for BLLN, versus a peer median of 140.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $505.13M | -12.7% | -12.9% | 43.7% | |
BLLNBillionToOne, Inc. | Jun 2026 | -$248.72M | +13.2% | — | 34.1% |
| Jun 2026 | -$323.43M | +26.1% | — | 21.8% | |
| Jun 2026 | -$448.67M | -13.1% | — | 33.2% | |
| Mar 2026 | -$1.16B | -52.8% | — | 171.7% | |
WGSGeneDx Holdings Corp. | Jun 2026 | -$1.45B | -7.9% | — | 302.1% |
| Jun 2026 | -$2.93B | -7.0% | — | 110.2% | |
| Sep 2026 | -$3.35B | -16.9% | — | 177.7% | |
| Jun 2026 | -$10.42B | -3.9% | — | 366.3% | |
| Peer median (excluding BLLN) | -$1.31B | -10.3% | -12.9% | 140.9% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.